Participation in The Small Cap Showcase

Summary by AI BETAClose X

Coiled Therapeutics plc announced that its executive management team will participate in The Small Cap Showcase in New York City on October 1, 2026, where they will present an overview of the company's business strategy, growth opportunities, recent developments, and outlook, and will also engage in one-on-one meetings with pre-qualified investors. The company is a clinical-stage precision oncology firm developing small molecule therapies for genetically defined cancers, with its lead program AO-252, a TACC3 inhibitor, currently in a Phase I clinical trial in the U.S. for ovarian and prostate cancers.

Disclaimer*

UK 100

Latest directors dealings